AB Science S.A. (EPA:AB)
France · Delayed Price · Currency is EUR 0.7300
+0.0250 (3.55%)
Sep 11, 2026, 5:35 PM CET
AB Science Revenue
In the year 2025, AB Science had annual revenue of 1.17M EUR with 9.51% growth. AB Science had revenue of 659.00K in the half year ending December 31, 2025, with 26.25% growth.
Revenue
1.17M
Revenue Growth
+9.51%
P/S Ratio
49.75
Revenue / Employee
37.87K
Employees
36
Market Cap
58.41M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17M | 102.00K | 9.51% |
| Dec 31, 2024 | 1.07M | 102.00K | 10.52% |
| Dec 31, 2023 | 970.00K | 11.72K | 1.22% |
| Dec 31, 2022 | 958.28K | -651.70K | -40.48% |
| Dec 31, 2021 | 1.61M | 26.97K | 1.70% |
| Dec 31, 2020 | 1.58M | 12.00K | 0.76% |
| Dec 31, 2019 | 1.57M | -130.00K | -7.64% |
| Dec 31, 2018 | 1.70M | -38.00K | -2.19% |
| Dec 31, 2017 | 1.74M | 231.00K | 15.32% |
| Dec 31, 2016 | 1.51M | -776.00K | -33.98% |
| Dec 31, 2015 | 2.28M | 185.00K | 8.81% |
| Dec 31, 2014 | 2.10M | 166.00K | 8.59% |
| Dec 31, 2013 | 1.93M | 593.00K | 44.25% |
| Dec 31, 2012 | 1.34M | 236.00K | 21.38% |
| Dec 31, 2011 | 1.10M | 187.00K | 20.39% |
| Dec 31, 2010 | 917.00K | 601.00K | 190.19% |
| Dec 31, 2009 | 316.00K | 315.00K | 31,500.00% |
| Dec 31, 2008 | 1.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Klea Holding | 22.17M |
| Fermentalg | 13.38M |
| MaaT Pharma | 4.52M |
| Adocia | 3.85M |
AB Science News
- 4 weeks ago - 3.4cr sign up for Ayushman Bharat, 80L for Bengal health scheme ahead of launch - The Times of India
- 3 months ago - AB Science is invited to present at the 2026 ENCALS annual meeting the survival data from masitinib clinical program in ALS - GlobeNewsWire
- 3 months ago - AB Science : Stonegate Capital Partners updates its coverage of AB Science's stock with a target price of EUR 4.25 per share - GlobeNewsWire
- 3 months ago - AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share - GlobeNewsWire
- 4 months ago - AB Science reports its revenues for the year 2025 and provides an update on its activities - GlobeNewsWire
- 4 months ago - AB Science Earnings release: H2 2025 - Filings
- 4 months ago - AB Science Annual report: H2 2025 - Filings
- 4 months ago - AB Science announces the successful completion of a EUR 3.2 million private placement - GlobeNewsWire